Qingdao Haier Biomedical Hits Day High with 10.81% Surge in Stock Price

Qingdao Haier Biomedical Co., Ltd. has experienced a significant uptick in its stock performance, gaining 10.81% on May 22, 2026. The stock reached an intraday high of CNY 37.15, marking a notable achievement for the company within the industrial manufacturing sector. In terms of performance metrics, Qingdao Haier Biomedical has shown a 1-day performance that outpaces the China Shanghai Composite, which recorded a modest gain of 0.87%. Over the past week, the company has also outperformed the index with an 8.33% increase compared to the composite's decline of 0.54%. Despite these short-term gains, the company has faced challenges in long-term growth, with a net profit decline of 49.8% in the first half of the year. The stock has consistently underperformed against the benchmark over the last three years, reflecting a complex financial landscape. With a market capitalization of CNY 10,798 million, Qingdao Haier Biomedical continues to navigate a competitive environment while striving for improved financial stability.